Nelson Rangel

Publicaciones

mRNA ratios of AR to ESR1 and PGR distinguish breast cancer subtypes based on public datasets and experimental models
2025-12-1
Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study
2024-4-19
Chromosomal Damage, Chromosome Instability, and Polymorphisms in GSTP1 and XRCC1 as Biomarkers of Effect and Susceptibility in Farmers Exposed to Pesticides
2024-4-1
Exploring chromosomal instability and clonal heterogeneity in breast cancer
2024-12-1
Profile of Chromosomal Alterations, Chromosomal Instability and Clonal Heterogeneity in Colombian Farmers Exposed to Pesticides
2022-2-24
Intrinsic subtypes and androgen receptor gene expression in primary breast cancer. A meta-analysis
2021-8-27
Obesity and androgen receptor signaling: Associations and potential crosstalk in breast cancer cells
2021-5-1
Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)
2020
Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines
2017-9-20
Tamoxifen resistance: Emerging molecular targets
2016-8-19
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: An in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells
2014-12-7
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: A clustering analysis
2014-1-23
Estudio citogenético en sangre periférica de pacientes con melanoma
2009-6-1
Evaluacuón de la expresión del factor de transcripción asociado con microftalmia (MITF) en sangre periférica de individuos con y sin melanoma maligno y en líneas celulares
2009-1-1

Coinvestigador

DETERMINACIÓN DE NUEVOS MARCADORES MOLECULARES (RECEPTOR DE ANDRÓGENOS-RA y GLI1) EN EL DIAGNOSTICO Y PRONÓSTICO DE CÁNCER DE SENO 2019-12-12 - 2024-03-30

Mejore su perfil